114. 非ジストロフィー性ミオトニー症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 13 / 薬物数 : 14 - (DrugBank : 4) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 9
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Dichlorphenamide
National Center for Research Resources (NCRR)
1992 Phase 3 NCT00004802 -
Lamotrigin actavis
Grete Andersen
2013 - EUCTR2013-003309-24-DK Denmark
Lamotrigin ”nordic prime 100 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigin ”nordic prime 25 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigin ”nordic prime 50 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigine
Grete Andersen
2013 - EUCTR2013-003309-24-DK Denmark
Grete Andersen, MD
2022 - NCT05639257 Denmark
2013 Phase 3 NCT01939561 Denmark
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigine 25MG oral tablet, extended release
University College, London
2021 Phase 3 NCT05017155 United Kingdom
Mexiletina cloridrato
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2015 Phase 2 EUCTR2014-002627-10-IT Italy
Mexiletine
Assistance Publique - Hôpitaux de Paris
2011 Phase 3 NCT02336477 France
Dept. of Neurology - Univ. of Kansas Medical Center
2010 - EUCTR2009-011184-36-IT Italy;United Kingdom
Radboud University
2014 Phase 2 NCT02045667 Netherlands
Radboud University Nijmegen Medical Center
2012 - EUCTR2010-024026-38-NL Netherlands
Richard Barohn, MD
2008 Phase 2 NCT00832000 Canada;Italy;United Kingdom;United States
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
University College, London
2021 Phase 3 NCT05017155 United Kingdom
Mexitil
Radboud University Nijmegen Medical Center
2012 - EUCTR2010-024026-38-NL Netherlands
Mexitil*20CPS 200MG
Dept. of Neurology - Univ. of Kansas Medical Center
2010 - EUCTR2009-011184-36-IT Italy;United Kingdom
Namuscla
Grete Andersen, MD
2022 - NCT05639257 Denmark
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Ranolazine
Ohio State University
2014 Phase 1 NCT02251457 United States
Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2015 Phase 2 EUCTR2014-002627-10-IT Italy
National Center for Research Resources (NCRR)
1992 Phase 3 NCT00004802 -
Lamotrigin actavis
Grete Andersen
2013 - EUCTR2013-003309-24-DK Denmark
Lamotrigin ”nordic prime 100 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigin ”nordic prime 25 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigin ”nordic prime 50 MG
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigine
Grete Andersen
2013 - EUCTR2013-003309-24-DK Denmark
Grete Andersen, MD
2022 - NCT05639257 Denmark
2013 Phase 3 NCT01939561 Denmark
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Lamotrigine 25MG oral tablet, extended release
University College, London
2021 Phase 3 NCT05017155 United Kingdom
Mexiletina cloridrato
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2015 Phase 2 EUCTR2014-002627-10-IT Italy
Mexiletine
Assistance Publique - Hôpitaux de Paris
2011 Phase 3 NCT02336477 France
Dept. of Neurology - Univ. of Kansas Medical Center
2010 - EUCTR2009-011184-36-IT Italy;United Kingdom
Radboud University
2014 Phase 2 NCT02045667 Netherlands
Radboud University Nijmegen Medical Center
2012 - EUCTR2010-024026-38-NL Netherlands
Richard Barohn, MD
2008 Phase 2 NCT00832000 Canada;Italy;United Kingdom;United States
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
University College, London
2021 Phase 3 NCT05017155 United Kingdom
Mexitil
Radboud University Nijmegen Medical Center
2012 - EUCTR2010-024026-38-NL Netherlands
Mexitil*20CPS 200MG
Dept. of Neurology - Univ. of Kansas Medical Center
2010 - EUCTR2009-011184-36-IT Italy;United Kingdom
Namuscla
Grete Andersen, MD
2022 - NCT05639257 Denmark
Rigshospitalet, department of Neurology
2022 Phase 3 EUCTR2021-003784-94-DK Denmark
Ranolazine
Ohio State University
2014 Phase 1 NCT02251457 United States
Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2015 Phase 2 EUCTR2014-002627-10-IT Italy